Skip to main content

Advertisement

Fig. 3 | BMC Cancer

Fig. 3

From: Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

Fig. 3

Characterization of CD8 infiltrating cells in NBL before the vaccination. IHC was performed on consecutive sections of FFPE tumor samples that were stained for Tbet, GZMB and PD-1 markers. Examples of immune infiltrating cells with nuclear Tbet, granular cytoplasmic GZMB or membrane PD-1 positive staining are indicated by arrows. Scale bar = 100 μm. For higher magnification, see Additional file 5: Figure S4

Back to article page